Extension through Nov. 11, 2023, gives DEA and HHS a chance to consider revisions and public comments regarding proposals offered March 1
Persons receiving medication for opioid use disorder more likely to be older, White and to have public insurance
Only 26.2 percent of children with parent-reported ADHD had ever received outpatient mental health care
Proof-of-concept study is 'encouraging' for repurposing insomnia drug, authors say
Additionally, chronic disease prevalence higher in the incarcerated population
These low added therapeutic-rating drugs accounted for $19.3 billion or one-third of Medicare annual net spending in 2020
Older Americans think they take too many medicines, and a sizable percentage said they have cut back
Median monthly retention rate was 22.2 percent during January 2016 through April 2022
The U.S. Food and Drug Administration approved OTC Narcan nasal spray last month to be sold without a prescription
However, no significant association seen for clinician-rated severity with EQ-5D-5L utility and Sheehan Disability Scale